NIAID funds collaborative HIV vaccine project with $9.8M grant

03/11/2014 | Xconomy

A seven-year, $9.8 million grant from the National Institute of Allergy and Infectious Diseases will fund a collaborative effort led by Seattle BioMed to develop two new candidates for an HIV vaccine. Rockefeller University, the University of Washington, the Seattle Children's Hospital and the Fred Hutchinson Cancer Research Center will participate in the project to develop a vaccine that prompts the body to generate broadly neutralizing antibodies against HIV-1.

View Full Article in:

Xconomy

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA